Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.
Disclosed holdings
$76.4M
1-day change
▲ 1.21%
Positions on file
3
issuers disclosed in Forms 3/4/5 and Schedules 13D/G
Disclosed holdings over time
31 weekly points
What the 3
currently disclosed positions would have been worth at each week’s
closing price. A rising line means the shares got more valuable, not that this
person bought more.
How the line is builti
Share counts are as last reported to the SEC and held constant; only prices move.
2026-02-06$43.5M – $93.7M2026-09-04
Insider activity Sep 26, 2024 – Feb 6, 2026
Aaron Cowen is recorded in filings to the U.S. SEC via EDGAR as
member of the board, and
reported 54
transactions between Sep 26, 2024 and Feb 6, 2026. The buy and sell totals below count only
codes P, S.
Why the other codes are excludedi
Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.
Open-market buys (code P)
$46.24M
49 purchases on filepriced rows only
Open-market sales (code S)
None
0 sales on file
All reported transactions
54
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window
Events from filings
Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.
Aaron Cowen sold 750,000 Veradermics, Inc (MANE) shares for $80,437,500 on Aug 19, 2026
Large trade for this person
Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.
Aaron Cowen sold 750,000 Veradermics, Inc (MANE) shares for $80,437,500 on Aug 19, 2026
Total of the rows above: $80,437,500, in the currency the filings report.
Summary written by an AI model from the filing data above (model: gemini-3.7-flash):
Aaron Cowen sold 750,000 shares of Veradermics, Inc through open-market sale transactions on 2026-08-19 for a total of $80,437,500.
The transactions included 690,601 shares sold at $107.25 per share for $74,066,957, leaving 2,957,937 shares held. An additional open-market sale of 59,399 shares was executed at $107.25 per share for $6,370,543, leaving 461,033 shares held.
Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.
4 insiders bought Veradermics, Inc (MANE) shares worth $34,817,458 between Feb 4, 2026 and Feb 6, 2026
Cluster buying
4 different insiders made 23 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.
4 insiders bought Veradermics, Inc (MANE) shares worth $34,817,458 between Feb 4, 2026 and Feb 6, 2026
Total of the rows above: $34,817,458, in the currency the filings report.
Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.
Aaron Cowen bought 53,344 Veradermics, Inc (MANE) shares for $1,979,596 on Feb 4, 2026
Large trade for this person
Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.
Aaron Cowen bought 53,344 Veradermics, Inc (MANE) shares for $1,979,596 on Feb 4, 2026
Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.
Aaron Cowen bought 1,481,481 Benitec Biopharma Inc. (BNTC) shares for $19,999,994 on Nov 7, 2025
Large trade for this person
Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.
Aaron Cowen bought 1,481,481 Benitec Biopharma Inc. (BNTC) shares for $19,999,994 on Nov 7, 2025
Total of the rows above: $19,999,994, in the currency the filings report.
Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.
Aaron Cowen bought 900,000 Benitec Biopharma Inc. (BNTC) shares for $11,700,000 on Mar 26, 2025
Large trade for this person
Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.
Aaron Cowen bought 900,000 Benitec Biopharma Inc. (BNTC) shares for $11,700,000 on Mar 26, 2025
Total of the rows above: $11,700,000, in the currency the filings report.
Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.
Reported transactions
Price 0.00 is a real reported figure
on gifts (G) and share awards (A) — not a missing number.
The 25 most recent rows are grouped into 6 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 58 on file in total. See the full history on EDGAR ↗
How to read this listi
Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.
The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.
Veradermics, IncMANEX In-the-money option exercise × 2not a buy/sell decisionreported at zero300,000 shares$0
The 2 lots that make up this line, each with the source behind it.
Shares is the amount
on the form;
value is that amount times the closing price shown. Rows with no closing
price are left blank, so they may add up to less than the headline figure.
What is not counted herei
Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.
Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer
Ticker
Security
Shares
Close
Value
Form
Reported
Filing
Veradermics, Inc
MANE
Common stock, par value $0.00001 per share (indirect)
